Survey: Support growing in Canada for decriminalizing all drugs for personal use

Drug decriminalization

More than a million Americans have lost their lives in this century on account of drug overdoses.

In Canada, the number of daily opioid-related deaths has grown dramatically, from eight in 2016 to 21 in 2022. This crisis is not going away, and the views of the two country’s residents can differ greatly.

Research Co. and Glacier Media asked Canadians and Americans earlier this month about the current situation.

In Canada, we see no change on one item from our previous survey in 2021: 45 per cent of the country’s residents describe the current situation related to the use of prescription and non-prescription opioid drugs in their community as “a major problem.” In the United States, 60 per cent of Americans call the opioid crisis “a major problem,” up seven points since our poll in 2020.

There is a significant gender gap when it comes to the perceptions of the opioid crisis. Two-thirds of American women (66 per cent) and half of Canadian women (50 per cent) concur about the gravity of the problem. The proportions of men who feel the same way are lower in both the United States (53 per cent) and Canada (38 per cent).

Canadians and Americans find common ground on some possible solutions. More than four in five endorse two courses of action: launching more education and awareness campaigns about drug use (84 per cent in Canada and 88 per cent in the United States) and creating more spaces for drug rehabilitation (82 per cent in Canada and 84 per cent in the United States).

Three in four Canadians and Americans (75 per cent in each country) also think it is time to reduce the prescription of opioids by medical professionals. In Canada, where this component has not been debated as heavily as in the United States, support for this policy is up by six points.

Majorities in each country agree with two other ideas: establishing “safe supply” programs where alternatives to opioids can be prescribed by health professionals (74 per cent in Canada and 80 per cent in the United States) and setting up more “harm reduction” strategies, such as legal supervised injection sites (63 per cent in Canada and 56 per cent in the United States).

On a different proposal, the perceptions of Canadians and Americans are growing apart. For the first time, two in five Canadians (40 per cent, up seven points) are in favour of decriminalizing all drugs for personal use. In the United States, just over a third of residents feel the same way (35 per cent, down 12 points).

Politically, the notion of a blanket drug decriminalization resonates positively with Canadians who voted for the New Democrats (50 per cent) and the Liberals (48 per cent) in the 2021 federal election, but not with those who cast ballots for Conservative candidates (27 per cent). In the United States, the fluctuations are not as severe: 40 per cent among Democrats, 34 per cent among Independents and 31 per cent among Republicans.

Age plays a big role in the national numbers. While 45 per cent of Canadians aged 18 to 34 would decriminalize all drugs for personal use, support drops to 41 per cent among those aged 35 to 54 and 34 per cent among those aged 55 and over. In the United States, most residents aged 18 to 34 (53 per cent) endorse decriminalization, compared with 36 per cent of those aged 35 to 54 and just 24 per cent of those aged 55 and over.

When asked to rate the performance of political leaders on the opioid crisis, Canadians are ambivalent. More than a third (36 per cent, up two points since 2021) rate the work of Prime Minister Justin Trudeau and the federal government as “very good” or “good.”

The satisfaction levels are similar for Canada’s mayors and councils (38 per cent, up one point), premiers and provincial governments (36 per cent, down three points), members of Parliament (34 per cent, up one point) and members of provincial legislatures (35 per cent, up two points)

The decline is precipitous for American policy makers. Only 34 per cent of Americans think President Joe Biden has handled the opioid crisis properly. Two years ago, almost half (46 per cent) thought Donald Trump was doing a good job.

We also see major drops in the proportion of Americans who are satisfied with the work of Congress (19 per cent, down 25 points), their governors and state administrations (36 per cent, down 22 points) and their mayors and local governments (39 per cent, down 19 points) to deal with the use of prescription and non-prescription opioid drugs in their community.

There is a continental consensus on some aspects of the opioid crisis, but not on others. While Canadians are just as worried as they were a year ago, they are now more supportive of decriminalization. Americans, who will participate within weeks in local and federal elections, appear to be more growing tired of their elected officials but are less likely to embrace a major policy change.

Mario Canseco is president of Research Co.

Results are based on online studies conducted from Oct. 15 to Oct. 17, 2022, among representative samples of 1,000 adults in Canada and the United States. The data has been statistically weighted according to Canadian and U.S. census figures for age, gender and region in each country. The margin of error – which measures sample variability – is plus or minus 3.1 percentage points, 19 times out of 20.

This article is written by or on behalf of an outsourced columnist and does not necessarily reflect the views of Castanet.

More Writer's Bloc articles

About the Author

Welcome to Writer’s Bloc, an opinion column for guest writers to share their experiences and viewpoints with our readers.

Do you have something to say that is timely? of local interest? controversial? inspiring? foodie? entertaining? educational?

Drop a line. [email protected]

Opinions expressed in this column are those of the writer and do not necessarily represent those of Castanet. They are not news stories reported by our staff.

The views expressed are strictly those of the author and not necessarily those of Castanet. Castanet does not warrant the contents.

Previous Stories